341 related articles for article (PubMed ID: 4923926)
1. A comparative trial of fenfluramine and diethylpropion inbesity.
Silverstone JT; Cooper RM; Begg RR
Br J Clin Pract; 1970 Oct; 24(10):423-5. PubMed ID: 4923926
[No Abstract] [Full Text] [Related]
2. A comparative trial of fenfluramine and diethylpropion in obese, hypertensive patients.
Follows OJ
Br J Clin Pract; 1971 May; 25(5):236-8. PubMed ID: 4931755
[No Abstract] [Full Text] [Related]
3. Hypotensive effect of fenfluramine in the treatment of obesity.
Practitioner; 1971 Jul; 207(237):101-5. PubMed ID: 5557039
[No Abstract] [Full Text] [Related]
4. A collaborative investigation of fenfluramine. Anorexigenic with sedative properties.
Elliott BW
Curr Ther Res Clin Exp; 1970 Aug; 12(8):502-15. PubMed ID: 4988837
[No Abstract] [Full Text] [Related]
5. A comparative trial of different regimens of fenfluramine and phentermine in obesity.
Steel JM; Munro JF; Duncan LJ
Practitioner; 1973 Aug; 211(262):232-6. PubMed ID: 4580610
[No Abstract] [Full Text] [Related]
6. A treatment for refractory obesity using fenfluramine without dietary restriction.
Sedgwick JP
Br J Clin Pract; 1970 Jun; 24(6):251-2. PubMed ID: 5456744
[No Abstract] [Full Text] [Related]
7. To the Editor: Fenfluramine (Poderax) for obesity.
Jackson WP
S Afr Med J; 1969 Sep; 43(39):1207. PubMed ID: 5353789
[No Abstract] [Full Text] [Related]
8. Diethylpropion hydrochloride: an effective appetite suppressant.
Bolding OT
Curr Ther Res Clin Exp; 1974 Jan; 16(1):40-8. PubMed ID: 4203847
[No Abstract] [Full Text] [Related]
9. Toxic and therapeutic effects of EMTP in obesity.
Hollingsworth DR; Amatruda TT
Clin Pharmacol Ther; 1969; 10(4):540-2. PubMed ID: 4893585
[No Abstract] [Full Text] [Related]
10. [Experience with the appetite depressant, fenfluramine hydrochloride, in adiposity].
Liebermeister H; Probst G; Jahnke K
Med Klin; 1969; 64(26):1201-7. PubMed ID: 5807324
[No Abstract] [Full Text] [Related]
11. Fenfluramine in obesity.
S Afr Med J; 1968 Jul; 42(27):682. PubMed ID: 5673819
[No Abstract] [Full Text] [Related]
12. [Fenfluramine. Anorexigenic drug in obstetrical practice].
RamÃrez Soto E; Delgado Urdapilleta J
Ginecol Obstet Mex; 1969 Apr; 25(150):425-32. PubMed ID: 5814199
[No Abstract] [Full Text] [Related]
13. [Administration of fenfluramine in double blind trial in patients with exogenous obesity. Analysis of therapeutic results and effects on lipid metabolism].
Toledo SP; Neto GA
Rev Bras Med; 1971 May; 28(5):240-5. PubMed ID: 4935137
[No Abstract] [Full Text] [Related]
14. Use of an anorexic drug in a total weight reduction program in private practice.
Nolan GR
Curr Ther Res Clin Exp; 1975 Aug; 18(2):332-7. PubMed ID: 809245
[No Abstract] [Full Text] [Related]
15. Fenfluramine up to date.
Drug Ther Bull; 1970 Mar; 8(6):21-3. PubMed ID: 5440616
[No Abstract] [Full Text] [Related]
16. Fenfluramine in the treatment of obesity.
Kneebone GM
Med J Aust; 1968 Nov; 2(19):833-5. PubMed ID: 5728209
[No Abstract] [Full Text] [Related]
17. Weight reduction in obesity.
Lawson AA; Gibson AM; Peattie P
Br Med J; 1969 Apr; 2(5651):246. PubMed ID: 5780438
[No Abstract] [Full Text] [Related]
18. Fenfluramine in obese patients on various antihypertensive drugs. Double-blind controlled trial.
Waal-Manning HJ; Simpson FO
Lancet; 1969 Dec; 2(7635):1392-5. PubMed ID: 4188278
[No Abstract] [Full Text] [Related]
19. Clinical aspects of the treatment of obesity by drugs: a review.
Munro JF
Int J Obes; 1979; 3(2):171-80. PubMed ID: 393645
[TBL] [Abstract][Full Text] [Related]
20. Drugs for obesity.
S Afr Med J; 1970 Apr; 44(16):461. PubMed ID: 5443299
[No Abstract] [Full Text] [Related]
[Next] [New Search]
